BEI
GILD icon

Benjamin Edwards Inc’s Gilead Sciences GILD Stock Holding History

Benjamin Edwards Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9M Sell
125,525
-6,539
-5% -$862K 0.14% 170
2026
Q1 		$18.4M Sell
132,064
-3,145
-2% -$440K 0.18% 144
2025
Q4 		$16.6M Sell
135,209
-33,468
-20% -$4.07M 0.18% 134
2025
Q3 		$18.7M Buy
168,677
+3,796
+2% +$431K 0.21% 119
2025
Q2 		$18.3M Sell
164,881
-10,054
-6% -$1.07M 0.23% 107
2025
Q1 		$19.6M Sell
174,935
-1,234
-0.7% -$127K 0.27% 98
2024
Q4 		$16.3M Sell
176,169
-189,651
-52% -$17.1M 0.23% 110
2024
Q3 		$30.7M Buy
365,820
+347,895
+1,941% +$26.5M 0.45% 61
2024
Q2 		$1.23M Buy
17,925
+125
+0.7% +$8.34K 0.24% 115
2024
Q1 		$1.3M Sell
17,800
-562
-3% -$43.2K 0.26% 102
2023
Q4 		$1.49M Sell
18,362
-3,735
-17% -$291K 0.32% 89
2023
Q3 		$1.66M Sell
22,097
-607
-3% -$46.7K 0.39% 73
2023
Q2 		$1.75M Sell
22,704
-4,218
-16% -$336K 0.41% 71
2023
Q1 		$2.23M Buy
26,922
+1,001
+4% +$82.9K 0.55% 52
2022
Q4 		$2.23M Buy
25,921
+788
+3% +$62.4K 0.59% 47
2022
Q3 		$1.55M Sell
25,133
-142
-0.6% -$8.95K 0.47% 64
2022
Q2 		$1.56M Buy
25,275
+3,153
+14% +$195K 0.46% 59
2022
Q1 		$1.31M Buy
22,122
+4,621
+26% +$295K 0.38% 78
2021
Q4 		$1.27M Buy
17,501
+1,475
+9% +$102K 0.41% 70
2021
Q3 		$1.12M Buy
16,026
+834
+5% +$58.6K 0.68% 41
2021
Q2 		$1.05M Sell
15,192
-145
-0.9% -$9.68K 0.72% 45
2021
Q1 		$991K Buy
15,337
+153
+1% +$9.87K 0.75% 44
2020
Q4 		$885K Buy
15,184
+4,961
+49% +$299K 0.69% 51
2020
Q3 		$646K Sell
10,223
-249
-2% -$17.3K 0.53% 68
2020
Q2 		$806K Buy
10,472
+2,156
+26% +$165K 0.67% 53
2020
Q1 		$622K Buy
8,316
+6,032
+264% +$417K 0.65% 52
2019
Q4 		$148K Buy
2,284
+4
+0.2% +$260 0.3% 76
2019
Q3 		$145K Buy
2,280
+110
+5% +$7.19K 0.31% 69
2019
Q2 		$147K Buy
2,170
+288
+15% +$18.9K 0.36% 57
2019
Q1 		$122K Buy
+1,882
New +$125K 0.58% 37

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Benjamin Edwards Inc's GILD Position: Q2 2026 in Review

Benjamin Edwards Inc reduced its Gilead Sciences (GILD) stake by 5% in Q2 2026, selling an estimated $862K and leaving 125,525 shares worth $15.9M. The position accounts for 0.14% of the portfolio, ranked #170.

Benjamin Edwards Inc first reported a position in GILD in Q1 2019 and has held it in 30 quarters since. The position peaked at $30.7M in Q3 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Benjamin Edwards Inc held 125,525 shares of Gilead Sciences worth $15.9M as of Q2 2026.
  • Benjamin Edwards Inc sold 6,539 Gilead Sciences shares in Q2 2026, an estimated $862K.
  • Gilead Sciences made up 0.14% of Benjamin Edwards Inc's portfolio in Q2 2026, its #170 holding.
  • Benjamin Edwards Inc first reported a position in Gilead Sciences in Q1 2019 and has held it in 30 quarters since.
  • Benjamin Edwards Inc's Gilead Sciences position peaked at $30.7M in Q3 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.